Schedule 13G ownership disclosure
GALMED PHARMACEUTICALS LTD
Security class unavailable · CUSIP: M47238122
Event date: 2023-07-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-082931
- Form type
- SC 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Jul 21, 2023
- Reporting period
- Jul 14, 2023
- Description
- Schedule 13G beneficial ownership